| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Total revenue | $289K-82.4% | $1.6M+17.1% | $1.4M+45.9% | $960K+58.4% | $606K+2.0% | $594K |
| Cost of revenue | $557K-31.3% | $811K+3.4% | $784K+195.8% | $265K-41.0% | $449K-5.5% | $475K |
| Gross profit | $461K-77.8% | $2.1M+12.6% | $1.8M+42.2% | $1.3M+725.5% | $157K+31.9% | $119K |
| Research and development | $4.6M-11.8% | $5.2M-40.3% | $8.7M+35.1% | $6.5M+9.6% | $5.9M+22.4% | $4.8M |
| General and administrative | $6.2M+55.0% | $4.0M-5.3% | $4.2M+5.8% | $4.0M+10.7% | $3.6M+15.0% | $3.1M |
| Sales and marketing | $242K-60.6% | $614K-46.0% | $1.1M-14.9% | $1.3M+3.7% | $1.3M+88.6% | $683K |
| Armor exit costs | $4.6M | — | — | — | — | — |
| Reduction in force | $407K | — | — | — | — | — |
| Grant and contract expenses | $156K-88.0% | $1.3M+15.3% | $1.1M+32.0% | $855K | — | — |
| Total operating expenses | $11.2M-30.6% | $16.1M+6.1% | $15.2M+20.3% | $12.6M+17.2% | $10.8M+25.0% | $8.6M |
| Loss from operations | -$10.7M+23.7% | -$14.0M-5.2% | -$13.4M-17.8% | -$11.3M-6.7% | -$10.6M-24.9% | -$8.5M |
| Interest expense | -$52K-79.3% | -$29K-1350.0% | -$2K+88.2% | -$17K+32.0% | -$25K | — |
| Interest income | $175K+63.6% | $107K-20.7% | $135K+487.0% | $23K-77.2% | $101K-69.4% | $330K |
| Gain (loss) on the disposal of assets | $327K+1821.1% | -$19K-211.8% | $17K+1800.0% | -$1K-100.7% | $144K | — |
| Change in fair value of derivative liabilities | -$124K-103.6% | $3.5M-39.2% | $5.7M+624.1% | -$1.1M-256.8% | $696K-67.0% | $2.1M |
| Offering costs of derivative liabilities | -$550K | — | -$786K | — | — | — |
| Other income (expense) | $31K-20.5% | $39K+129.4% | $17K-95.5% | $382K+9450.0% | $4K-98.6% | $282K |
| Total other income (expense), net | $357K-88.2% | $3.0M-40.7% | $5.1M+824.3% | -$704K-153.7% | $1.3M-11.1% | $1.5M |
| Net loss before income taxes | -$10.4M+6.0% | -$11.0M-33.5% | -$8.3M+31.4% | -$12.0M-29.3% | -$9.3M-32.4% | -$7.0M |
| Net loss | -$10.4M+6.0% | -$11.0M-33.5% | -$8.3M+31.4% | -$12.0M-29.3% | -$9.3M-32.4% | -$7.0M |
| Deemed dividend related to warrant inducement | -$6.7M | — | — | — | — | — |
| Net loss attributable to common stockholders | -$17.1M-55.0% | -$11.0M-33.1% | -$8.3M+49.8% | -$16.5M-77.1% | -$9.3M+43.9% | -$16.6M |
| Basic – net loss | -$4K+74.8% | -$15K+96.6% | -$442K-1007.4% | -$40K-5.9% | -$38K-8667.4% | -$430 |
| Basic – deemed dividend related to warrant inducement | -$2K | — | — | — | — | — |
| Basic – attributable to common stockholders | -$6K+58.6% | -$15K+96.6% | -$443K-711.2% | -$55K-45.0% | -$38K-3632.7% | -$1K |
| Diluted – net loss | -$4K+75.4% | -$15K+97.6% | -$623K-1232.1% | -$47K-17.2% | -$40K-7430.2% | -$530 |
| Diluted - deemed dividend related to warrant inducement | -$2K | — | — | — | — | — |
| Diluted – attributable to common stockholders | -$6K+59.4% | -$15K+97.6% | -$624K-926.9% | -$61K-52.4% | -$40K-3595.4% | -$1K |
| Basic | $2.77B+274.2% | $741.3M+3867.7% | $18.7M-93.8% | $301.6M+22.1% | $246.9M-98.5% | $16.41B |
| Diluted | $2.77B+272.4% | $744.8M+3318.6% | $21.8M-93.1% | $317.3M+26.6% | $250.7M-98.6% | $17.45B |
| Product [Member] | ||||||
| Grant and Contract [Member] | ||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.